DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ rose 2.15% to $123.53 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.47% to 5,686.67 and the Dow Jones Industrial Average rising 1.39% to 41,317.43.
Biogen Inc. closed 48.10% below its 52-week high of $238.00, which the company achieved on July 12th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 1.07% to $156.12, Pfizer Inc. $(PFE)$ rose 1.13% to $24.20, and AbbVie Inc. $(ABBV)$ rose 2.65% to $198.47.
Trading volume (1.5 M) remained 321,070 below its 50-day average volume of 1.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 2, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 02, 2025 17:08 ET (21:08 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.